BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15685932)

  • 61. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.
    Hömme M; Schmitt CP; Mehls O; Schaefer F
    J Am Soc Nephrol; 2004 Nov; 15(11):2844-50. PubMed ID: 15504937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
    Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK
    Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The carboxyl-terminal domains of MKP-1 and MKP-2 have inhibitory effects on their phosphatase activity.
    Hutter D; Chen P; Li J; Barnes J; Liu Y
    Mol Cell Biochem; 2002 Apr; 233(1-2):107-17. PubMed ID: 12083364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.
    Engelbrecht Y; de Wet H; Horsch K; Langeveldt CR; Hough FS; Hulley PA
    Endocrinology; 2003 Feb; 144(2):412-22. PubMed ID: 12538600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.
    Liu C; Shi Y; Du Y; Ning X; Liu N; Huang D; Liang J; Xue Y; Fan D
    Exp Cell Res; 2005 Oct; 309(2):410-8. PubMed ID: 16081065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling.
    Su J; Xie Q; Wilson I; Li L
    Cell Signal; 2007 Jul; 19(7):1596-601. PubMed ID: 17379480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
    Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
    J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge.
    Nelin LD; Wang X; Zhao Q; Chicoine LG; Young TL; Hatch DM; English BK; Liu Y
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C632-40. PubMed ID: 17442735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation.
    Li J; Gorospe M; Hutter D; Barnes J; Keyse SM; Liu Y
    Mol Cell Biol; 2001 Dec; 21(23):8213-24. PubMed ID: 11689710
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
    Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.
    Chen P; Li J; Barnes J; Kokkonen GC; Lee JC; Liu Y
    J Immunol; 2002 Dec; 169(11):6408-16. PubMed ID: 12444149
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
    Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
    Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
    Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
    J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Caron M; Atfi A; Cherqui G; Capeau J
    Endocrinology; 2000 Mar; 141(3):922-31. PubMed ID: 10698166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes.
    Fischer TA; Singh K; O'Hara DS; Kaye DM; Kelly RA
    Am J Physiol; 1998 Sep; 275(3):H906-16. PubMed ID: 9724295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells.
    Jang BC; Lim KJ; Suh MH; Park JG; Suh SI
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):171-84. PubMed ID: 17645739
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contribution of MKP-1 regulation of p38 to endotoxin tolerance.
    Nimah M; Zhao B; Denenberg AG; Bueno O; Molkentin J; Wong HR; Shanley TP
    Shock; 2005 Jan; 23(1):80-7. PubMed ID: 15614136
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone.
    Khan TA; Bianchi C; Ruel M; Voisine P; Li J; Liddicoat JR; Sellke FW
    Circulation; 2003 Sep; 108 Suppl 1():II348-53. PubMed ID: 12970258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.